• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    DexCom, Inc. - Common Stock (NQ:DXCM)

    58.22 -9.98 (-14.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about DexCom, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    31 32 Next >
    Exploring the top movers within the S&P500 index during today's session.
    Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session. 
    Via Chartmill
    Discover which S&P500 stocks are making waves on Friday.
    Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
    Via Chartmill
    Why DexCom (DXCM) Stock Is Falling Today
    Shares of medical device company DexCom (NASDAQ:DXCM) fell 14.8% in the afternoon session after the company reported underwhelming earnings. 
    Via StockStory
    Topics Artificial Intelligence Economy Government
    Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup
    Via Stocktwits
    Earnings Scheduled For October 30, 2025
     
    Via Benzinga
    An Overview of DexCom's Earnings
     
    Via Benzinga
    Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
    Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive. 
    Via Benzinga
    Why DexCom Stock Is Crashing Today
    The diabetes equipment provider had a strong quarter, but next year is looking weaker than expected. 
    Via The Motley Fool
    Topics Earnings
    Gapping S&P500 stocks in Friday's session
    Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
    Via Chartmill
    Top S&P500 movers in Friday's pre-market session
    The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
    Via Chartmill
    DXCM Q3 Deep Dive: Margin Pressures Offset Strong Diabetes Access and Product Expansion
    Medical device company DexCom (NASDAQ:DXCM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s... 
    Via StockStory
    Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook
    Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled. 
    Via Investor's Business Daily
    Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    These S&P500 stocks are moving in today's after hours session
    As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment. 
    Via Chartmill
    DexCom Inc (NASDAQ:DXCM) Reports Q3 2025 Earnings Beat Amid Stock Plunge on Guidance Concerns
    DexCom Q3 2025 earnings beat estimates, but stock fell due to full-year revenue guidance that missed analyst expectations. 
    Via Chartmill
    Topics Earnings
    12 Health Care Stocks Moving In Thursday's After-Market Session
     
    Via Benzinga
    DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops
    Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be... 
    Via StockStory
    What Does the Market Think About DexCom Inc?
     
    Via Benzinga
    Should You Buy DexCom Stock Before Oct. 31?
    The company hasn't had a great year. Is it about to turn things around? 
    Via The Motley Fool
    Topics Lawsuit
    Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
    Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
    Via Benzinga
    Topics Economy
    DexCom (DXCM) Reports Earnings Tomorrow: What To Expect
    Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know. 
    Via StockStory
    DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor
    Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify. 
    Via Benzinga
    Topics Death Lawsuit
    Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices
    Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023. 
    Via Stocktwits
    Topics Death Economy
    Forecasting The Future: 13 Analyst Projections For DexCom
     
    Via Benzinga
    2 Stocks Down 17% and 21% to Buy Right Now
    Both companies have faced recent challenges, but look likely to overcome them. 
    Via The Motley Fool
    Topics World Trade
    Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment
    Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season. 
    Via StockStory
    Topics Artificial Intelligence
    Dexcom Inc (NASDAQ:DXCM) Fits the Affordable Growth Strategy with Solid Expansion and Sensible Pricing
    Dexcom offers strong growth in diabetes care with solid profitability and a reasonable valuation, fitting an affordable growth investment strategy. 
    Via Chartmill
    DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know
    A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
    Via StockStory
    Topics Economy Government World Trade
    1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm
    A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
    Via StockStory
    Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
    Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    31 32 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.